Antimicrobial resistance (AMR) poses a significant challenge in healthcare and public health, with organisms such as nontyphoidal Salmonella leading the way due to their escalating resistance to antimicrobial agents. This situation severely complicates the management and containment of diseases, highlighting the urgent need for more effective techniques to assess antimicrobial susceptibility. Conventional methods, including the broth microdilution technique for determining Minimum Inhibitory Concentrations (MICs), are time-consuming and require extensive manual effort. The advent of machine learning (ML) technologies offers a revolutionary approach to predicting MICs, thereby potentially increasing the efficacy of antimicrobial therapies. This paper explores the latest advancements in ML for MIC prediction, focusing on an innovative approach using Graph Neural Networks (GNNs), which could provide a novel insight into the correlation between gene fragment similarities and MIC values. Within this paper, we introduce the K-mer GNN, a novel GNN model designed for MIC prediction. The K-mer GNN model distinctively identifies and incorporates the similarities among k-mers, integrating these insights into GNN alongside k-mer features. This approach not only elevates the precision of MIC predictions but also sheds light on the genomic factors at the k-mer level that drive antimicrobial resistance.

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC53108.2024.10782350DOI Listing

Publication Analysis

Top Keywords

mic prediction
12
antimicrobial resistance
12
graph neural
8
neural networks
8
k-mer gnn
8
gnn model
8
antimicrobial
6
mic
5
leveraging graph
4
networks mic
4

Similar Publications

Background: Critically ill children are at risk for subtherapeutic antibiotic concentrations. The frequency of target attainment and risk factors for subtherapeutic concentrations of cefepime in children have not been extensively studied.

Methods: We performed an observational study in critically ill children receiving a new prescription of standard dosing of cefepime for suspected sepsis (≥2 systemic inflammatory response syndrome criteria within 48 hours of cefepime start).

View Article and Find Full Text PDF

Novel treatment options are needed for the gastric pathogen due to its increasing antibiotic resistance. The vitamin K analogue menadione has been extensively studied due to interest in its anti-bacterial and anti-cancer properties. Here, we investigated the effects of menadione on growth, viability, antibiotic resistance, motility and gene expression using clinical isolates.

View Article and Find Full Text PDF

Pharmacokinetics of Ampicillin-Sulbactam in Azotemic and Non-Azotemic Dogs.

J Vet Pharmacol Ther

March 2025

Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Science, Colorado State University, Fort Collins, Colorado, USA.

Previous research has shown that azotemic dogs have a lower clearance and higher drug plasma concentrations of ampicillin compared to healthy dogs. The objective of this study was to determine the pharmacokinetics of ampicillin-sulbactam after multiple intravenous doses in hospitalized azotemic and non-azotemic dogs. This prospective study included 29 client-owned dogs; 19 azotemic and 10 non-azotemic.

View Article and Find Full Text PDF

Background: The emergence of β-lactamase-producing bacteria limits the effectiveness of β-lactam (BL) antibiotics, and the combination with a β-lactamase inhibitor (BLI) aims to counteract this resistance. However, existing guidelines primarily focus on optimizing the dosing of BLs and do not adequately address the interaction between BLs and BLIs, leading to uncertain pharmacokinetic/pharmacodynamic (PK/PD) targets and potentially suboptimal dosing strategies.

Objectives: To investigate optimal PK/PD targets and dosing strategies for avibactam (BLI) combined with ceftazidime (BL) using mechanism-based PKPD models.

View Article and Find Full Text PDF

Predicting Kidney Outcomes in Autosomal Dominant Polycystic Kidney Disease: a Comprehensive Biomarker Analysis.

Clin J Am Soc Nephrol

March 2025

Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Background: Risk stratification tools for Autosomal Dominant Polycystic Kidney Disease (ADPKD) predict kidney outcomes on a group level but lack precision in individuals.

Methods: We assessed the value of adding 13 prognostic biomarkers to established risk factors (sex, age, estimated glomerular filtration rate (eGFR), systolic blood pressure, Mayo Imaging Class (MIC), and mutation type) for predicting disease progression. We included 596 patients from the DIPAK (Developing Intervention strategies to halt Progression of Autosomal Dominant Polycystic Kidney Disease) cohorts with ≥2 eGFR measurements and ≥1 year follow-up.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!